全部股東
股東類型
- 機構投資者43.13%
- 公眾及其他37.40%
- 個人與內幕人士14.83%
- 上市公司3.22%
- 私人企業1.42%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
JPMorgan Chase & Co. | 8.96% | 3,043.73 萬 | 1.23% | +418.16 萬 | 21/07/2026 |
State Street Investment Management | 7.04% | 2,393.03 萬 | 1.65% | -561.54 萬 | |
Andreas KlugeChief Medical Advisor | 6.67% | 2,267.50 萬 | 0.01% | +0 | |
Christian BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 6.41% | 2,179.69 萬 | <0.01% | +6.79 萬 | 26/05/2026 |
Challenger Limited | 4.98% | 1,690.73 萬 | 0.07% | -19.52 萬 | |
Citigroup Inc. | 3.35% | 1,139.14 萬 | 0.01% | +6.04 萬 | 30/06/2026 |
Grand Pharmaceutical Group Limited | 3.22% | 1,094.72 萬 | <0.01% | +0 | |
Vanguard Capital Management, LLC | 3.12% | 1,059.30 萬 | <0.01% | +2.07 萬 | 31/07/2026 |
Australian Super Pty Ltd | 2.26% | 768.79 萬 | <0.01% | +0 | 31/12/2025 |
Vanguard Investments Australia Limited | 1.88% | 640.17 萬 | 0.02% | +6.70 萬 | 31/07/2026 |
BlackRock, Inc. | 1.75% | 595.87 萬 | 0.02% | -5.14 萬 | 30/06/2026 |
UV-Cap GmbH & Co KG | 1.44% | 487.83 萬 | <0.01% | +0 | |
Norges Bank Investment Management | 1.35% | 459.90 萬 | 0.54% | -183.01 萬 | 30/06/2026 |
Mark NelsonIndependent Non-Executive Director | 1.07% | 362.88 萬 | <0.01% | +0 | 18/03/2026 |
Oncidium Foundation | 0.74% | 251.36 萬 | <0.01% | +0 | |
Netwealth Investments Ltd. | 0.71% | 240.66 萬 | <0.01% | +0 | |
BetaShares Capital Limited | 0.59% | 200.52 萬 | 0.02% | +5.15 萬 | 31/08/2026 |
Sanlam Investments Uk Limited | 0.58% | 195.95 萬 | <0.01% | +0 | 30/06/2025 |
Lightpoint Medical Ltd | 0.56% | 191.81 萬 | <0.01% | +0 | |
Yelwac Pty Ltd | 0.52% | 176.25 萬 | <0.01% | +0 |